ZYDUS LIFESCIENCES LIMITED

Overview

• HeadquartersAhmedabad, India¹
• Legal formPublic Limited Company¹
• LEI335800R9O14ORBXLPN13¹
• StatusActive¹
• LEI statusIssued and current¹
• Registered addressZYDUS CORPORATE PARK,SCHEME NO. 63, 382481 Ahmedabad, India¹
• Registered withMinistry of Corporate Affairs, L24230GJ1995PLC025878¹

See how the biggest companies compare on our leaderboards

Corporate structure

ZYDUS LIFESCIENCES LIMITED sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

Subsidiaries and ownership

Subsidiaries (GLEIF)

• Zydus Wellness²

Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Timeline

1. May 14, 1995Founded ZYDUS LIFESCIENCES LIMITED is founded¹

Calendar

Drug trials and FDA: recently

1. Jul 18, 2024FDA approval FDA approved Zituvimet Xr (metformin hydrochloride) (NDA 216778).³
2. Nov 3, 2023FDA approval FDA approved Zituvimet (metformin hydrochloride) (NDA 216743).⁴

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar